Hydroxytyrosyl alkyl ether derivatives inhibit platelet activation after oral administration to rats
Hydroxytyrosyl alkyl ether derivatives inhibit platelet activation after oral administration to rats
复制标题
DOI:
10.1016/j.fct.2013.04.045
复制
发表时间:
2013-08-01
影响因子:
4.3
通讯作者:
Antonio Gonzalez-Correa, Jose
中科院分区:
文献类型:
--
作者:
Munoz-Marin, Javier;Pedro De La Cruz, Jose;Antonio Gonzalez-Correa, Jose
The low lipophilicity of hydroxytyrosol (HT) has motivated efforts to synthesize homologous series with better lipid solubility, such as the ethers, which are more lipophilic than HT. Because HT inhibits platelet aggregation, the aim of the study was to assess the possible anti-platelet effect of five HT ether derivatives (ethyl, butyl, hexyl, octyl and dodecyl) after oral administration to rats. Whole blood collagen-induced platelet aggregation and calcium-induced thromboxane B-2 (TxB(2)) aortic 6-keto-prostaglandin F-1 alpha (6-keto-PGF(1 alpha)) and nitrites + nitrates, plasma concentration of lipid peroxides (TBARS) and red blood cell content of reduced glutathione (GSH) were measured. The administration of 20 mg/kg/day inhibited platelet aggregation, TxB(2) and TBARS in a non-linear manner related to the length of the carbon chain, with a cut-off effect in the hexyl derivative. Aortic nitrite and red blood cell GSH production were also increased. The aortic production of 6-keto-PGF(1 alpha), was unaltered except in the group treated with the dodecyl derivative. The administration of 50 mg/kg/day showed a similar pharmacodynamic profile but without the non-linear effect. In conclusion, HT ethers, especially the hexyl derivative, are a potential alternative to hydroxytyrosol, and their effect merits additional research to determine their role in the prophylaxis of vascular disease. (C) 2013 Elsevier Ltd. All rights reserved.